CLONEX-A

This brand name is authorized in Nigeria.

Active ingredients

The drug CLONEX-A contains a combination of these active pharmaceutical ingredients (APIs):

1	Betamethasone UNII 9842X06Q6M - BETAMETHASONE
	Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties.
	Read more about Betamethasone
2	Tolnaftate UNII 06KB629TKV - TOLNAFTATE
	Read more about Tolnaftate
3	Gentamicin UNII T6Z9V48IKG - GENTAMICIN
	Gentamicin is usually bactericidal in action. Although the exact mechanism of action has not been fully elucidated, the drug appears to inhibit protein synthesis in susceptible bacteria by irreversibly binding to 30S ribosomal subunits.
	Read more about Gentamicin
4	Clioquinol UNII 7BHQ856EJ5 - CLIOQUINOL
	Read more about Clioquinol

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-1497	Cream	CLONEX A CREAM CREAM 0.643mg; 1mg; 10mg; 10mg 1 X 30G	57 CMS-PP-372872 CLONEX A CREAM BETAMETHASONE DIPROPIONATE 0.63MG, GENTAMIC BASE 1MG, TOLNAFTATE USP 10MG ,LODOCHLORHYDROXYQUINOLINE 10MG - betamethasone Dipropionate USP- 0.643mg, Gentamicin sulphate BP- 1.0mg, Iodochlorhydroxy quinolone BP- 10mg, Tolnaftate USP – 10mg, Other Ingredients- cetostearyl alcohol, cetomacragol 1000, liquid paraffin, white soft paraffin, BHT, disodium EDTA, Sodium dihydrogen phosphate, propylene glycol and purified water. B4-1497 Drugs Imported Products 1x30g Prescription Only Medicine (POM) 11/5/2023 MAYDON PHARMACEUTICAL LIMITED., WILMER STREET, OFF TOWN PLANNING, ILUPEJU, LAGOS LAGOS 1740194511 maydonp@outlook.com MAXHEAL LABORATORIES PVT LTD, PLOT NO. 2-7/80-85 SURSEZ SACHIN DIST. SURAT GUJARAT 394 230 INDIA, India	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D07CC01	Betamethasone and antibiotics	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07C Corticosteroids, combinations with antibiotics → D07CC Corticosteroids, potent, combinations with antibiotics
Discover more medicines within D07CC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-1497